Compounds > hydralazine

hydralazine and olmesartan

hydralazine has been researched along with olmesartan in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (35.71)	29.6817
2010's	9 (64.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Seko, Y	1
Abe, S; Ishihara, M; Ishizawa, K; Izawa, Y; Kanematsu, Y; Kawazoe, K; Motobayashi, Y; Ohnishi, H; Tamaki, T; Tsuchiya, K	1
Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N	1
de Souza Mendonça, L; Fernandes-Santos, C; Mandarim-de-Lacerda, CA	1
Araki, S; Hirooka, Y; Kishi, T; Sunagawa, K; Utsumi, H; Yasukawa, K	1
Eldawoody, H; Kimura, N; Nakayama, T; Saito, A; Shimizu, H; Takahashi, A; Tominaga, T	1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H	1
Hatipoglu, FO; Hirohata, S; Iwamoto, M; Kusachi, S; Miyoshi, T; Ninomiya, Y; Ogawa, H; Ohtsuki, T; Shinohata, R; Yamamoto, K	1
Deguchi, K; Hitomi, H; Kitada, K; Kobori, H; Lei, B; Masaki, T; Minamino, T; Mori, H; Nakano, D; Nishiyama, A	1
Hara, T; Hayden, MR; Hitomi, H; Ichimura, A; Ito, S; Kaifu, K; Kawachi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsumoto, S; Nishijima, Y; Nishiyama, A; Ohsaki, H; Sofue, T; Sowers, JR; Urushihara, M; Whaley-Connell, A	1
Fujigaki, Y; Fukasawa, H; Hishida, A; Huang, Y; Ichihara, A; Ikegaya, N; Misaki, T; Nishiyama, A; Ohashi, N; Senbonmatsu, T; Suzuki, H; Togawa, A; Yamamoto, T	1
Ichikawa, H; Kimura, Y; Kinjo, T; Narita, I; Nishizaki, K; Okumura, K; Osanai, T; Tanaka, M; Tanno, T; Tomita, H	1
Chang, TT; Chen, JS; Chen, JW; Huang, PH; Lin, LY; Lin, SJ; Wu, TC	1

Other Studies

14 other study(ies) available for hydralazine and olmesartan

Article	Year
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3. Clinical science (London, England : 1979), 2006, Volume: 110, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cytokines; Deoxyguanosine; Drug Evaluation, Preclinical; Enterovirus B, Human; Enterovirus Infections; Genome, Viral; Heart Rate; Hydralazine; Imidazoles; Inflammation Mediators; Lymphocyte Activation; Male; Mice; Mice, Inbred C3H; Myocarditis; Tetrazoles; Vasodilator Agents	2006
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Heart Rate; Hemodynamics; Hemoglobins; Hydralazine; Hypertension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tetrazoles	2006
Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein. American journal of hypertension, 2007, Volume: 20, Issue:10 Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dietary Proteins; Disease Models, Animal; Endothelium, Vascular; Hydralazine; Hypertension, Renovascular; Imidazoles; Kidney; Male; Metabolic Syndrome; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Tetrazoles	2007
Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats. Heart and vessels, 2009, Volume: 24, Issue:3 Topics: Animals; Antihypertensive Agents; Blood Pressure; Hydralazine; Hypertension; Imidazoles; Male; Myocytes, Cardiac; Rats; Tetrazoles; Ventricular Remodeling	2009
Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Brain; Electron Spin Resonance Spectroscopy; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Imidazoles; Male; NADPH Oxidases; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tetrazoles	2009
Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats. Brain research, 2010, Mar-31, Volume: 1322 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cerebral Arteries; Circle of Willis; Corrosion Casting; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelial Cells; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Intracranial Aneurysm; Microscopy, Electron, Scanning; Pravastatin; Rats; Tetrazoles; Treatment Outcome; Vasodilator Agents	2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney international, 2010, Volume: 78, Issue:11 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography	2010
Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:12 Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Connective Tissue Growth Factor; Echocardiography; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart; Hydralazine; Imidazoles; Immunohistochemistry; Male; Myocardium; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transforming Growth Factor beta1	2010
Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice. American journal of hypertension, 2012, Volume: 25, Issue:3 Topics: Actins; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cellular Senescence; Eplerenone; Genes, p16; Genes, p53; Hydralazine; Hypertension; Imidazoles; Kidney; Mice; Mice, Inbred C57BL; p21-Activated Kinases; Sirtuin 1; Sodium Chloride; Spironolactone; Tetrazoles	2012
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. American journal of hypertension, 2012, Volume: 25, Issue:5 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydralazine; Hydrochlorothiazide; Imidazoles; Juxtaglomerular Apparatus; Male; Membrane Proteins; Podocytes; Rats; Rats, Inbred OLETF; Reserpine; Tetrazoles	2012
Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake. American journal of physiology. Renal physiology, 2012, Jul-01, Volume: 303, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antilymphocyte Serum; Blood Pressure; Hydralazine; Imidazoles; Kidney; Male; Nephritis; Prorenin Receptor; Rats; Rats, Wistar; Receptors, Cell Surface; Renin; Sodium Chloride, Dietary; T-Lymphocytes; Tetrazoles	2012
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression. Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:6 Topics: Animals; Blood Pressure; Cardiomegaly; Fibrosis; Gene Expression; Hydralazine; Imidazoles; Male; Mice; Myocytes, Cardiac; NADPH Oxidases; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Signal Transduction; Tetrazoles	2016
Aliskiren directly improves endothelial progenitor cell function from Type II diabetic patients. European journal of clinical investigation, 2016, Volume: 46, Issue:6 Topics: Amides; Antihypertensive Agents; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Diabetes Mellitus, Type 2; Endothelial Progenitor Cells; Fumarates; Humans; Hydralazine; Imidazoles; In Vitro Techniques; Nitric Oxide Synthase Type III; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tetrazoles; Vascular Endothelial Growth Factor A	2016